Effectiveness of adenovirus-mediated gene transfer with CTLA4Ig in allo and xeno-transplantation.
Hayashi
S
S
Department of Surgery II, Nagoya University School of Medicine, Nagoya, Japan.
Dai-Kaku
L
L
Namii
Y
Y
Kato
T
T
Tokoro
T
T
Kobayashi
T
T
Yokoyama
I
I
Hamada
H
H
Nakao
A
A
D000069594:Abatacept; D000256:Adenoviridae; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000235:genetics* / Q000276:immunology; D060908:CTLA-4 Antigen; D006224:Cricetinae; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors; D006085:Graft Survival / Q000502:physiology*; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D006801:Humans; D018796:Immunoconjugates; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents; D008647:Mesocricetus; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D014183:Transplantation, Heterologous / Q000502:physiology*; D014184:Transplantation, Homologous / Q000502:physiology*; D001616:beta-Galactosidase / Q000235:genetics
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D000069594:Abatacept; D001616:beta-Galactosidase